See the barriers. Clear the way. Start at the Center on Health Equity & Access.
Men’s Health Month 2025: Spotlight on Prostate Cancer, Lifelong Health
Understanding the Mental Health Burden of Chronic Allergies and Early Diagnosis: Insights From Thermo Fisher's Gary Falcetano
Factors That Increase Utilization Management Risk: A Proof of Concept
Managed Care Cast News Roundup: June 3, 2025
ACP Experts Say FDA, CDC Moves May Undermine COVID-19 Vaccine Coverage for Millions
Workers Facing Greater Economic Hardship More Likely to Report Poor Health
Health Equity & Access Weekly Roundup: June 2, 2025
Equitable Access to Lupus Treatment Essential for Improving Minority Patient Outcomes: Margrit Wiesendanger, MD, PhD
Ovarian, Breast Cancer Disparities Highlight Need for Better Screening: CK Wang, MD
Dialysis Outcomes Tied to Nephrologist Facility Quality, Widening Racial Inequities
Future of Mental Health Parity Landscape Up in the Air Based on Trump Administration Actions: Ali Khawar
Caregiver Dependence Is Key to HIV Care in Children: Priscilla Tsondai, MD, MPH
Global Trends Show Growing Impact of Low Physical Activity on Kidney Health
Next Steps: Post-Frontline Therapies and Resistance in ALK+ NSCLC
Balancing Clinical Benefits and Costs of BTK Inhibitors
CROI 2025 Insights: Evolving HIV Treatment Landscape and Practice-Changing Developments
Closing Perspectives
How Can PET Cardiac Stress Testing Prevent Invasive Procedures? Merrill Stewart, MD
Relacorilant Plus Nab-Paclitaxel Improves Outcomes in Platinum-Resistant Ovarian Cancer: Brian Slomovitz, MD
Combination of Albuterol/Budesonide a Game-Changer in Mild Asthma: Reynold Panettieri, Jr, MD
Impact of Access Challenges on Patient Outcomes in CLL and MCL Care
Long-Acting Injectable Lenacapavir Works in Both Prevention, Treatment of HIV: Gordon Crofoot, MD, PA
AI Use in Thoracic Medicine Continues to Evolve in Diagnostic Capabilities: Samir Shah, MD, MMM, FACR
Relacorilant Plus Nab-Paclitaxel Improves Outcomes in Platinum-Resistant Ovarian Cancer: Brian Slomovitz, MD
Combination of Albuterol/Budesonide a Game-Changer in Mild Asthma: Reynold Panettieri, Jr, MD
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
AI Use in Thoracic Medicine Continues to Evolve in Diagnostic Capabilities: Samir Shah, MD, MMM, FACR
Weighing Drug Costs and Patient Values in Cancer Care
Cancer Care Innovations Abound, but Access and Equity Are Ongoing Challenges
Translating Best Practices and Ensuring Equitable Care as the Treatment Landscape Evolves
Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits
Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare
An Assessment of Nurse Practitioner Low-Value Care Use in Primary Care
Standardized Testing, Moves to Oral Therapy, and Cost Challenges Get Attention
More Is Not Always Better: Innovations in Oncology Treatment and Diagnostics
Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited
Impact of Hospital-Physician Integration on Medicare Patient Mix
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
Navigating Next-Generation Therapies for the Management of Acid-Related Disorders